Slide 1: Ansell FY25 Half Year Results
ANSELL FY25 HALF YEAR RESULTS 10 February 2025
Slide 2: Disclaimer and Non-IFRS Measures
HALF YEAR RESULTS FY25 Disclaimer and Non-IFRS Measures The following presentation has been prepared by Ansell Limited (Ansell or the Company) for information purposes only. The information contained in this presentation is a summary only and does not purport to be complete. It should be read in con
Slide 3: Contents and Key Highlights
HALF YEAR RESULTS FY25 Contents 1 2 3 4 5 6 Drivers of Topics Performance KBU & APIP Financial FY25 Q&A Overview Updates Growth & Results Outlook Sustainability Double-digit top Results from KBU Continued Strong financial Increasing Key Highlights and bottom-line acquisition ahead investment in long
Slide 4: 1. Performance Overview
1. Performance Overview 4
Slide 5: Strong Delivery Against Key Performance Objectives
HALF YEAR RESULTS FY25 Strong Delivery Against Key Performance Objectives FY25 H1 Performance Highlights Summary Financials Our Stated Goals At Start Of FY25 Progress During FY25 H1 FY25 Organic ($m)1 • Organic CC2 sales growth in Industrial and 16.3% growth2 in Healthcare, 8.1% in Industrial H1 C
Slide 6: Good Growth Achieved By All SBUs
HALF YEAR RESULTS FY25 Good Growth Achieved By All SBU’s Industrial Segment Healthcare Segment Organic Constant Currency1 growth: 8.1% Organic Constant Currency1 growth: 16.3% Mechanical Chemical Exam/SU Surgical Cleanroom Org CC1 growth: 10.9% Org CC1 growth: 5.7% Org CC1 growth: 9.3% Org CC1 growt
Slide 7: 2. KBU & APIP Updates
2. KBU & APIP Updates 7
Slide 8: KBU Performance & Integration Progress Ahead Of Business Case
HALF YEAR RESULTS FY25 KBU Performance & Integration Progress Ahead Of Business Case The acquisition of the KBU PPE business from Kimberly-Clark Corporation accelerates our growth strategy and generates scale benefits. FY25 H1 • Sales of $140.9m, Organic CC1 sales growth of 7.4% Performance – Strong
Slide 9: APIP Progressing To Plan
HALF YEAR RESULTS FY25 APIP Progressing To Plan On track to achieve FY26 annualised pre-tax savings target of $50m, excluding longer-dated IT savings. Focus of program shifting to ERP upgrades in FY26. FY25 H1 Pre-Tax Work Stream & Objective FY25 H1 Progress Update P&L Cost ($m) Organisation Simplif
Slide 10: 3. Key Growth Drivers & Sustainability
3. Key Growth Drivers & Sustainability 10
Slide 11: Investing To Strengthen Long Term Growth & Differentiation
HALF YEAR RESULTS FY25 Investing To Strengthen Long Term Growth & Differentiation Leading Positions In Comprehensive Service Solutions Resilient Supply Sustainability Strong Cash Growing Markets Product Portfolio Valued By Customers Chain Leadership Flows Recent Actions New customer-focused Commerci
Slide 12: Global, Diversified Supply Chain Provides Flexibility
HALF YEAR RESULTS FY25 Global, Diversified Supply Chain Provides Flexibility Ansell retains the flexibility to respond to changes in the relative attractiveness of traditional PPE manufacturing locations through 14 owned manufacturing plants in 9 countries and an extensive partner network. Key Comme
Slide 13: Progress Against 2040 Sustainability Action Plan
HALF YEAR RESULTS FY25 Progress Against 2040 Sustainability Action Plan People Planet We are a recognised leader for safe, respectful and inclusive We pioneer new solutions that reduce our environmental workplaces in our industry impact across our operations and support a healthier planet Target Pro
Slide 14: 4. Financial Results
4. Financial Results 14
Slide 15: Double-Digit Organic CC Sales & Earnings Growth
HALF YEAR RESULTS FY25 Double-Digit Organic CC 1 Sales & Earnings Growth P&L Summary Key Comments ($m) FY24 H1 FY25 H1 %∆ Org CC1 % ∆ • 12.5% Organic CC1 sales growth, including strong growth Sales 784.9 1,019.7 29.9% 12.5% in both Industrial and Healthcare Cost of Goods Sold (486.3) (620.9) 27.7% 1
Slide 16: Industrial Growth Supported By New Products
HALF YEAR RESULTS FY25 Industrial Growth Supported By New Products Industrial Segment – P&L Summary Sales Performance ($m) FY24 H1 FY25 H1 %∆ Org CC1 % ∆ • Organic CC1 sales growth due to increased sales of new products and Sales 384.4 457.4 19.0% 8.1% greater traction with higher price and performa
Slide 17: Healthcare Rebound On Destocking Recovery
HALF YEAR RESULTS FY25 Healthcare Rebound On Destocking Recovery Healthcare Segment – P&L Summary Sales Performance ($m) FY24 H1 FY25 H1 %∆ Org CC1 % ∆ • Organic CC1 sales growth driven by higher volumes across all SBU’s Sales 400.5 562.3 40.4% 16.3% • Growth in Exam/SU and Cleanroom included higher
Slide 18: Input Costs Higher Across Key Raw Materials
HALF YEAR RESULTS FY25 Input Costs Higher Across Key Raw Materials FY25 H1 Input Cost Trends • NBR and NRL costs higher versus FY24 H1. Majority of synthetics and yarns stable • Employee cost inflation persists in key manufacturing locations, including additional social compliance costs, with immine
Slide 19: Strong Cash Flow Supporting Growth Investments
HALF YEAR RESULTS FY25 Strong Cash Flow Supporting Growth Investments (7.2) 3.2 (10.1) (28.2) (19.3) (18.7) FY25 133.8 129.8 (31.7) H1 0.0 1.4 (635.1) 53.5 ($m) (611.9) EBITDA Working Other Net Receipts Lease Net Capex Net Interest Taxes Operating Dividend Buyback FX Net Debt Acquisitions NIBD Capit
Slide 20: Strengthening Balance Sheet, Improvement in ROCE
HALF YEAR RESULTS FY25 Strengthening Balance Sheet, Improvement in ROCE Balance Sheet Summary Key Comments ($m) Dec-23 Jun-24 Dec-24 • Strong balance sheet with Moody’s Baa2 investment grade Fixed Assets 362.0 349.3 362.1 rating Intangibles 1,062.0 1,054.8 1,638.2 • Working capital at 31-Dec-24 incl
Slide 21: Significant Liquidity, Leverage Reducing Post-KBU Acquisition
HALF YEAR RESULTS FY25 Significant Liquidity, Leverage Reducing Post-KBU Acquisition Net Debt Summary Key Comments ($m) Dec-23 Jun-24 Dec-24 • Net Debt increased $609m versus 30-Jun-24 due to consideration Interest-Bearing Debt 422.6 766.3 737.7 paid for the KBU acquisition Cash at Bank and Short-Te
Slide 22: 5. FY25 Outlook
Ansell 5. FY25 Outlook
Slide 23: FY25 H2 Priorities
HALF YEAR RESULTS FY25 FY25 H2 Priorities Build on strong organic growth momentum in FY25 H1, complete KBU integration, sustain productivity benefits. Sales Growth Through Differentiated Operational Excellence Enhancing Disciplined Capital Allocation Building Customer Solutions Productivity & Custom
Slide 24: FY25 Guidance Range Increased
HALF YEAR RESULTS FY25 FY25 Guidance Range Increased Increasing FY25 Adjusted EPS1 guidance range from US110¢ to US127¢, to US118¢ to US128¢. Market Conditions Key Guidance Assumptions2 Cash Flow & Capital Management • Solid healthcare demand, post- • Continued Organic Constant Currency3 sales growt
Slide 25: Reinforcing Our Investment Proposition
HALF YEAR RESULTS FY25 Reinforcing Our Investment Proposition Leading Positions Comprehensive Service Solutions Resilient Supply Sustainability Strong Cash In Growing Markets Product Portfolio Valued By Customers Chain Leadership Flows Share gain opportunity Continuing to AnsellGUARDIAN® Manufacturi
Slide 26: 6. Q&A
6. Q&A 26
Slide 27: Appendix
Appendix 27
Slide 28: Sales & EBIT Impact Of FX Movements
HALF YEAR RESULTS FY25 Sales & EBIT Impact Of FX Movements FX Impact ($m) Key Comments Sales EBIT FY25 H1 vs FY24 H1 • Net reduction in sales and EBIT, largest adverse movements were in FX Rate Movements (2.5) (3.1) the MYR and BRL FX Gain/(Loss) Variance – Hedge • Net foreign exchange loss on hedge
Slide 29: Organic Constant Currency
HALF YEAR RESULTS FY25 Organic Constant Currency Constant Currency Restated Prior Period ($m) • The presentation of constant currency information is designed to Industrial Healthcare Corporate Group facilitate comparability of reported earnings by restating the prior Prior Period Sales period’s resu
Slide 30: Segment History
HALF YEAR RESULTS FY25 Segment History ($m) FY141 FY151 FY161 FY171 FY181 FY191 FY201 FY211 FY22 FY23 FY24 1H191 1H201 1H211 1H22 1H23 1H24 1H25 Ansell Sales 1,377.5 1,428.1 1,352.8 1,374.5 1,489.8 1,499.0 1,613.7 2,026.9 1,952.1 1,655.1 1,619.3 725.3 753.3 937.8 1,009.2 835.3 784.9 1,019.7 2,3,4,5
Slide 31: Ansell Fact Sheet
HALF YEAR RESULTS FY25 Ansell Fact Sheet Key Figures Key FY25 Assumptions • Booked Tax Losses at 31 December 2024: $18.9m (Australia $15.6m) • FY25 forecast foreign exchange exposures by currency: Revenue currencies: USD 60%, EUR 22%, GBP 3%, CAD 3%, AUD 3% • Unbooked Tax Losses at 31 December 2024:
Slide 32: Glossary
HALF YEAR RESULTS FY25 Glossary APIP – Accelerated Productivity Investment Program FX – Foreign Exchange NBR – Nitrile Butadiene Rubber AUD – Australian Dollar FY23 – Financial Year 2023 NIBD – Net Interest-Bearing Debt BRL – Brazilian Real FY24 – Financial Year 2024 NRL – Natural Rubber Latex CAD –
Slide 33: Ansell
Ansell Lead the world to a safer future. www.ansell.com